Items where authors include "Fog, LS"

Article

Espensen, CA, Kiilgaard, JF, Klemp, K et al. (3 more authors) (2021) 3D image‐guided treatment planning for Ruthenium‐106 brachytherapy of choroidal melanomas. Acta Ophthalmologica, 99 (5). e654-e660. ISSN 1755-375X

Espensen, CA, Kiilgaard, JF, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (5 more authors) (2020) Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas. Ophthalmology. ISSN 0161-6420

Gram, V, Fog, LS, Hemer, M et al. (5 more authors) (2020) Patient reported upper gastro-intestinal symptoms associated with fractionated image-guided conformal radiotherapy for metastatic spinal cord compression. Technical Innovations & Patient Support in Radiation Oncology, 13. pp. 1-5. ISSN 2405-6324

Espensen, CA, Appelt, AL orcid.org/0000-0003-2792-9218, Fog, LS et al. (4 more authors) (2020) Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas. Acta Oncologica, 59 (8). pp. 918-925. ISSN 0284-186X

Espensen, CA, Appelt, A orcid.org/0000-0003-2792-9218, Fog, LS et al. (3 more authors) (2019) Predicting Visual Acuity Deterioration and Radiation-Induced Toxicities after Brachytherapy for Choroidal Melanomas. Cancers, 11 (8). 1124. ISSN 2072-6694

Espensen, CA, Jensen, PK, Fog, LS et al. (5 more authors) (2017) Ultrasonic mirror image from ruthenium plaque facilitates calculation of uveal melanoma treatment dose. British Journal of Ophthalmology, 101 (9). pp. 1206-1210. ISSN 0007-1161

Proceedings Paper

Espensen, CA, Thariat, J, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (6 more authors) (2017) NTCP-based prediction of maculopathy after proton therapy or Ruthenium-106 brachytherapy for choroidal melanomas. In: Investigative Opthalmology & Visual Science. 2017 ARVO Annual Meeting, 07-11 May 2017, Baltimore, Md, USA. Association for Research in Vision and Opthalmology .